| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
DPP4 inhibitor| 1 | 2008 | Emerging role of dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes. | 
| + | - | nl | Vasc Health Risk Manag 4(4):753-68 (2008) |
| 2 | 2008 | New combination treatments in the management of diabetes: focus on sitagliptin-metformin. | 
| + | - | nl | Vasc Health Risk Manag 4(4):743-51 (2008) |
| 3 | 2008 | Novel combination treatment of type 2 diabetes DPP-4 inhibition + metformin. | 
| + | - | nl | Vasc Health Risk Manag 4(2):383-94 (2008) |
| 4 | 2008 | Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential. | 
| + | - | nl | Vasc Health Risk Manag 4(6):1221-7 (2008) |
| 5 | 1999 | Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review). | 
| + | - | nl | Int J Mol Med 4(1):3-15 (1999) |